rs1539243 — IKBKE IKBKE Ile67 synonymous variant

IKBKE — When the Innate Immune Alarm Misfires

The IKBKE gene¹¹ IKBKE gene
Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Epsilon, located at chromosome 1q32.1, encoding the IKKε kinase — a central switch in innate antiviral immunity and inflammatory signalling plays a dual role in human immunity that has made it one of the more interesting targets in autoimmune genetics. When a virus enters the body and triggers innate immune sensors, IKKε is one of the kinases that phosphorylates IRF3 and IRF7 — the transcription factors responsible for producing type I interferons (IFN-α/β), the body's frontline antiviral broadcast. The same enzyme also activates NF-κB, the master regulator of inflammatory gene expression. Get the balance right and you clear a virus efficiently. Let IKKε run unchecked and you drive excessive type I interferon production — one of the hallmarks of systemic lupus erythematosus (SLE).

rs1539243 sits in exon 4 of IKBKE and is a synonymous coding variant: the C and T alleles both encode isoleucine at codon 67 (Ile67), leaving the protein sequence unchanged. Its clinical relevance comes not from altering the protein itself but from its tight linkage with regulatory haplotypes that modulate IKBKE expression in immune cells — particularly in antigen-presenting cells where IKKε expression is critical for calibrating the IFN response.

The Mechanism

IKKε (encoded by IKBKE) is a noncanonical IκB kinase related to TBK1. Its canonical role is phosphorylating IRF3 and IRF7²² phosphorylating IRF3 and IRF7
Interferon regulatory factors 3 and 7 — nuclear transcription factors that, once phosphorylated by IKKε or TBK1, dimerize and translocate to the nucleus to drive IFN-β and IFN-α gene transcription. This phosphorylation occurs downstream of Toll-like receptors (TLR3, TLR4), RIG-I/MDA5 viral RNA sensors, and STING. Alongside IRF activation, IKKε phosphorylates IκBα to release and activate NF-κB, amplifying a broader pro-inflammatory gene program including TNF, IL-6, and CXCL chemokines.

The paradox of IKBKE in SLE is expression-level: SLE patients show significantly reduced IKBKE mRNA expression³³ significantly reduced IKBKE mRNA expression
approximately 1.92-fold lower in SLE peripheral blood compared to healthy controls, P=2.32×10⁻¹² rather than overexpression. The working model is that the IKBKE locus haplotype alters IKKε expression in a cell-type- and context-specific manner — in monocytes, the SLE-risk rs2297550-G allele is associated with higher IKBKE expression under basal conditions but lower expression in IFN-stimulated monocytes, B cells, and NK cells. The result is a dysregulated IFN feedback loop rather than a simple up-or-down change, consistent with the chronically elevated type I interferon signature characteristic of SLE.

The Evidence

The case for IKBKE as an SLE susceptibility gene rests on two complementary studies. The first, by Gateva et al. 2011⁴⁴ Gateva et al. 2011
"A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE", screened 78 interferon pathway genes across 2,136 SLE cases and 9,694 controls (Swedish and US cohorts). rs1539243 (C allele) emerged with OR 1.19 (95% CI 1.09–1.31, P=0.00026) in the combined meta-analysis — a modest but robustly replicated risk effect.

The second, by Wang et al. 2013⁵⁵ Wang et al. 2013
"Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility", deep-resequenced the full IKBKE locus in 1,140 SLE patients and 2,060 controls. Two independent IKBKE association signals were identified, with the combined haplotype carrying both risk alleles reaching OR 1.68 (P=1.0×10⁻⁵) — a substantially larger effect than the tag SNP alone captures. This confirmed that the IKBKE locus harbours multiple partially independent variants that jointly raise SLE susceptibility.

A third study by Pan et al. 2020⁶⁶ Pan et al. 2020
"The decreased expression of IKBKE in systemic lupus erythematosus" demonstrated in peripheral blood that IKBKE expression loss correlates with vasculitis involvement and elevated CRP in SLE patients, providing biological plausibility for why IKBKE variation would be clinically meaningful beyond its statistical association.

The rs1539243 C allele has also been reported in a study of symptomatic dengue in Colombian children⁷⁷ a study of symptomatic dengue in Colombian children
Ramirez et al. 2018, Viral Immunology, where IKBKE haplotypes were associated with resistance to symptomatic dengue — consistent with IKKε's role in antiviral innate immunity. The same genetic architecture that modestly increases autoimmune risk may confer benefit in certain infectious disease contexts, illustrating the evolutionary trade-off common to immune regulatory genes.

The evidence level is moderate: IKBKE association with SLE has been independently replicated, the biological mechanism is coherent, but the individual SNP effect is modest (OR ~1.19) and no CPIC/DPWG or clinical actionability guidelines exist.

Practical Actions

For carriers of the CC or CT genotype, the primary implication is awareness of elevated SLE susceptibility and vigilance for early autoimmune symptoms. SLE is more common in women (9:1 ratio) and in people of African, Asian, and Hispanic descent, so this variant should be interpreted in the context of other SLE risk factors. The IKBKE variant alone does not predict SLE — it modestly increases background risk as one of many genetic inputs.

Practically, supporting innate immune regulation through established lifestyle factors (adequate sleep, omega-3 fatty acids for anti-inflammatory signalling) is relevant for anyone with elevated SLE susceptibility, though the specific value of each measure for IKBKE carriers has not been studied in trials.

Interactions

The strongest genetic interaction at this locus involves rs2297550, an IKBKE 5' UTR variant with promoter and enhancer activity in immune cells. rs2297550 is in linkage disequilibrium with rs1539243 and may be the primary functional variant driving the observed association; the two should be interpreted together where genotyping permits.

rs1539241 and rs12142086 tag two independent IKBKE association signals identified by deep resequencing (Wang et al. 2013) — the haplotype comprising both risk alleles carries OR 1.68. Anyone carrying the rs1539243 C risk allele is likely also carrying one or both of these deeper IKBKE haplotype signals.

Within the type I interferon pathway, IKBKE works in concert with TBK1 (which has overlapping kinase substrates) and IRF5, IRF7, and STAT4 — all of which have independently replicated SLE GWAS associations. Convergence of risk alleles across multiple interferon pathway genes substantially increases cumulative SLE risk beyond any single variant.